webinar register page

Webinar banner
Session-2 Developer’s perspective: Fexinidazole for African trypanosomiasis / 第2回「開発者の視点:アフリカトリパノソーマ症(アフリカ睡眠病)の治療薬フェキシニダゾールについて」
Session 2 focuses on fexinidazole, a new drug for treatment of African trypanosomiasis. This medicine was developed a few years ago in partnership with DNDi, Sanofi and many other organizations. DNDi and its partners are currently working together to deliver fexinidazole in African countries. Fexinidazole can be seen as a promising story of a drug developer engaging in delivering NTD medicines. The invited speakers will identify key access challenges and how DNDi has addressed them.

[Language] English (Simultaneous translation into Japanese available)
[Fee] Free
[Organizer] Japan Alliance on Global Neglected Tropical Diseases (JAGntd)
[Sponsor] GHIT Fund


【後援】グローバルヘルス技術振興基金(GHIT Fund)

Oct 14, 2021 04:00 PM in Osaka, Sapporo, Tokyo

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: .